Last mentioned: Mar 17, 2026
BlackRock has announced quarterly distributions for three major healthcare-focused iShares ETFs, reflecting the varied cash flow profiles across the pharmaceutical, medical device, and healthcare provider sub-sectors. The distributions, led by the $0.2845 per share payout for the U.S. Pharmaceuticals ETF (IHE), come as investors weigh sector-specific regulatory pressures against robust balance sheets.
This page surfaces every story mentioning iShares U.S. Pharmaceuticals ETF across our finance coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running finance beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where iShares U.S. Pharmaceuticals ETF was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |